Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11365)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2014 (publication date) through Jan 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lehmann FS, Trapani F, Fueglistaler I, Terracciano LM, von Flüe M, Cathomas G, Zettl A, Benkert P, Oertli D, Beglinger C. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma. World J Gastroenterol 2014; 20(17): 4994-4999 [PMID: 24803811 DOI: 10.3748/wjg.v20.i17.4994] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i17/4994.htm |
| Number | Citing Articles |
| 1 |
Gülden Sincan, Emel Ayvaz, Fuat Erdem, Ahmet Kiziltunç. The importance of serum calprotectin level in patients with lymphoma. Iraqi Journal of Hematology 2023; 12(1): 98 doi: 10.4103/ijh.ijh_54_22
|
| 2 |
Stephan R Vavricka, Henriette Heinrich, Simon Buetikofer, Flavia Breitenmoser, Emanuel Burri, Xiaoye Schneider-Yin, Jasmin Barman-Aksoezen, Luc Biedermann, Michael Scharl, Jonas Zeitz, Gerhard Rogler, Benjamin Misselwitz, Matthias Sauter. The Vampire Study: Significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding. United European Gastroenterology Journal 2018; 6(7): 1007 doi: 10.1177/2050640618774416
|
| 3 |
Emel Eşer, Burhan Engin, Pelin Yüksel, Bekir Sami Kocazeybek, Zekayi Kutlubay, Server Serdaroğlu, Özge Aşkın. Relationship between fecal calprotectin level and disease activity in patients with hidradenitis suppurativa. Dermatologic Therapy 2020; 33(2) doi: 10.1111/dth.13232
|
| 4 |
Jennifer Murray, Klaartje B Kok, Ruth M Ayling. Fecal Calprotectin in Gastrointestinal Disease. Clinical Chemistry 2023; 69(7): 699 doi: 10.1093/clinchem/hvad051
|
| 5 |
Zong-Ran Chen, Gang Liu. Fecal calprotectin and colorectal cancer. World Chinese Journal of Digestology 2019; 27(23): 1436 doi: 10.11569/wcjd.v27.i23.1436
|
| 6 |
Paula Moravkova, Darina Kohoutova, Jaroslava Vavrova, Jan Bures. Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study. Scandinavian Journal of Clinical and Laboratory Investigation 2020; 80(3): 173 doi: 10.1080/00365513.2019.1704050
|
| 7 |
Parisa Khosravi, Saeid Abroun, Saeid Kaviani, Saman Masoudifar, Homayoun Sarough Farahani, Antonio Solimando. Calprotectin as new potential clinical marker for multiple myeloma. PLOS ONE 2023; 18(3): e0282841 doi: 10.1371/journal.pone.0282841
|
| 8 |
Anna-Maija Puolanne, Sami Qadri, Tiina Vesterinen, Saara Hiltunen, Aaro Mustonen, Samu Kurki, Kaija-Leena Kolho, Johanna Arola, Martti Färkkilä. Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?. Scandinavian Journal of Gastroenterology 2022; 57(11): 1304 doi: 10.1080/00365521.2022.2084345
|
| 9 |
Frank S. Lehmann, Emanuel Burri, Christoph Beglinger. The role and utility of faecal markers in inflammatory bowel disease. Therapeutic Advances in Gastroenterology 2015; 8(1): 23 doi: 10.1177/1756283X14553384
|
| 10 |
Fiona A. Ross, James H. Park, David Mansouri, Emilie Combet, Paul G. Horgan, Donald C. McMillan, Campbell S. D. Roxburgh. The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02220-1
|
| 11 |
Juana Mosele, Alba Macià, Maria-José Motilva. Metabolic and Microbial Modulation of the Large Intestine Ecosystem by Non-Absorbed Diet Phenolic Compounds: A Review. Molecules 2015; 20(9): 17429 doi: 10.3390/molecules200917429
|
| 12 |
Tsukasa Yamakawa, Takakazu Miyake, Yoshihiro Yokoyama, Tomoe Kazama, Yuki Hayashi, Daisuke Hirayama, Shinji Yoshii, Hiro‐o Yamano, Satoshi Takahashi, Hiroshi Nakase. Clinical performance of fecal calprotectin, lactoferrin, and hemoglobin for evaluating the disease activity of IBD and detecting colorectal tumors. JGH Open 2024; 8(6) doi: 10.1002/jgh3.13077
|
| 13 |
Jennie Clough, Michael Colwill, Andrew Poullis, Richard Pollok, Kamal Patel, Sailish Honap. Biomarkers in inflammatory bowel disease: a practical guide. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241251600
|
| 14 |
Jianhua Zou, Zhanshuo Xiao, Yu Wu, Jingyan Yang, Ning Cui. Noninvasive fecal testing for colorectal cancer. Clinica Chimica Acta 2022; 524: 123 doi: 10.1016/j.cca.2021.10.030
|
| 15 |
S. Tabur, H. Korkmaz, M. Özkaya, U. Elboğa, M. Tarakçıoglu, N. Aksoy, E. Akarsu. Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma. Tumor Biology 2015; 36(10): 7549 doi: 10.1007/s13277-015-3468-1
|
| 16 |
Reza Ranjbar, Mohamad Ghasemian, Mahmood Maniati, Seyyed Hossein Khatami, Navid Jamali, Mortaza Taheri-Anganeh. Gastrointestinal disorder biomarkers. Clinica Chimica Acta 2022; 530: 13 doi: 10.1016/j.cca.2022.02.013
|
| 17 |
Paula Moravkova, Darina Kohoutova, Stanislav Rejchrt, Jiri Cyrany, Jan Bures. Role of S100 Proteins in Colorectal Carcinogenesis. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/2632703
|
| 18 |
Maria Ling Lundström, Christer Peterson, Charlotte R. H. Hedin, Daniel Bergemalm, Maria Lampinen, Maria K. Magnusson, Åsa V. Keita, Robert Kruse, Carl Mårten Lindqvist, Dirk Repsilber, Mauro D'Amato, Henrik Hjortswang, Hans Strid, Johan D. Söderholm, Lena Öhman, Per Venge, Jonas Halfvarson, Marie Carlson. Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD. Alimentary Pharmacology & Therapeutics 2024; 60(6): 765 doi: 10.1111/apt.18154
|
| 19 |
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of Gastroenterology 2016; 51(5): 434 doi: 10.1007/s00535-016-1182-4
|
| 20 |
Almina Jukic, Latifa Bakiri, Erwin F. Wagner, Herbert Tilg, Timon E. Adolph. Calprotectin: from biomarker to biological function. Gut 2021; 70(10): 1978 doi: 10.1136/gutjnl-2021-324855
|
| 21 |
Karen Queliza, Michael K. Wang, Richard Kellermayer. Compliance With Fecal Calprotectin Testing in Pediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2018; 66(6): 932 doi: 10.1097/MPG.0000000000001837
|
| 22 |
Nathalie Blad, Richard Palmqvist, Pontus Karling. Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09440-4
|
| 23 |
David Lundgren, Vincy Eklöf, Richard Palmqvist, Johan Hultdin, Pontus Karling. Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy. Scandinavian Journal of Gastroenterology 2019; 54(2): 152 doi: 10.1080/00365521.2019.1566493
|
| 24 |
Raúl Y. Tito, Sara Verbandt, Marta Aguirre Vazquez, Leo Lahti, Chloe Verspecht, Verónica Lloréns-Rico, Sara Vieira-Silva, Janine Arts, Gwen Falony, Evelien Dekker, Joke Reumers, Sabine Tejpar, Jeroen Raes. Microbiome confounders and quantitative profiling challenge
predicted microbial targets in colorectal cancer development. Nature Medicine 2024; 30(5): 1339 doi: 10.1038/s41591-024-02963-2
|